A Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of RBD4059 in Participants With Stable Coronary Artery Disease

NCT06717074 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Stable Coronary Artery Disease CAD

Interventions

DRUG: RBD4059
DRUG: Placebo

Sponsor

Ribocure Pharmaceuticals AB